Only 262,700 of the eligible 6.8 million smokers or ex-smokers underwent LDCT in 2015.
Changes to Medicaid reimbursements can improve cancer screening rates.
Second study shows no benefit from CRC screening more intensively than recommended.
Report details success of CDC program for women with limited health care access.
CHICAGO, IL— Implementing the U.S. Preventive Services Task Force (USPSTF) recommendation for annual low-dose computed tomography (LDCT) lung cancer screening among high-risk smokers will more than double the proportion of early-stage lung cancer diagnoses among Medicare beneficiaries.
Digital mammography screening with a direct radiography (DR) photon-counting system has good diagnostic performance.
Semiautomated computer-derived measurements of breast density are consistent with radiologist assessments.
The AAFP opposes the USPSTF recommendation for annual screening of high-risk adults for lung cancer due to insufficient evidence.
Among 1,000 U.S. women screened annually for 10 years, 0.3 to 3.2 will avoid breast cancer death.
Screening urged for adults aged 55 to 80 years with 30 pack-year history who smoke or recently quit.
Low-dose CT may result in overdiagnosis of lung cancer.
Report features 76 studies; highlights new approaches to cancer care, new treatments
Simple profiling tools are used to identify geriatric patients' risk profile for functional decline and survival.
A study presented at the RSNA annual meeting reports reduced callback rates and improved cancer detection with tomosynthesis compared with mammography.
There is currently insufficient evidence to weigh the benefits and harms of PCP screening of asymptomatic adults for oral cancer.
Two studies show that from 2005 to 2009, there was an increase in MRI screening for breast cancer.
A study from the NCI on comorbidity-adjusted life expectancy may help refine recommendations for cancer screenings.
A rise in screening rates for colon cancer was observed after a multicomponent intervention in rural communities.
The preliminary rate of lung cancer diagnosis using low-dose computed tomography (CT) screening is 7% at a Veterans Affairs Medical Center.
Initial results from the National Lung Screening Trial concur with the literature, with more positive screening results, diagnostic procedures, and lung cancers detected with low-dose CT versus chest radiography screening.
Optimal breast cancer screening should be personalized for each woman and may go beyond mammography, according to a review.
American Cancer Society stresses that stronger efforts to cut tobacco use and obesity and expand screening test use could prevent much of the suffering and deaths associated with cancer.
The number of benign findings for suspected lung cancers varies by state, suggesting a national lung cancer screening program would vary geographically, according to research presented at AACR 2013.
Reducing the tube voltage from 120 kVp to 100 kVp significantly reduces radiation dose while minimally reducing image quality, regardless of patient size.
Adoption of National Lung Screening Trial regimens could prevent 12,250 deaths/year in U.S.
Decreases in the rates of cancer screening may predict higher mortality from several common cancers.
Surveillance and methodology needed to assess impact of vaccines.
This fact sheet reviews current prostate cancer screening tests, guidelines, PSA, and risk factors.
Many adults aged 75 years or older routinely undergo cancer screening.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Resveratrol and Cancer
- Liquid Biopsies and Cancer Detection: New Test Assesses Levels of Circulating Proteins for Early-Stage Diagnosis
- Understanding Telomerase: Higher Quality Images Give Insight Into Developing New Agents for Inhibition
- ARID1A Mutations Might Predict Tumor Response to Immunotherapy
- Global Burden of Myeloma Increasing, Access to Treatments Lacking
- ENESTfreedom Study Reports Durable Treatment-Free Remission in Chronic Myeloid Leukemia After 96 Weeks
- Adding Rituximab to Prednisolone May Improve Long-Term Response in Immune Thrombocytopenia
- FDA Updates Restrictions for Pembrolizumab, Atezolizumab in Urothelial Carcinoma
- Longer Overall Survival with FOLFIRINOX Versus Gemcitabine/nab-Paclitaxel in Pancreatic Cancer
- Dendritic Cell Vaccine Plus Salvage Chemotherapy Active in Gastric Cancer